Loading...
•
Sep 30, 2020
IRadimed Q3 2020 Earnings Report
IRadimed reported a decrease in revenue and net income due to the challenging environment resulting from the pandemic.
Key Takeaways
IRadimed Corporation announced its Q3 2020 financial results, reporting a revenue of $7.7 million compared to $10.0 million for Q3 2019. Net income was $1.1 million, or $0.09 per diluted share, compared to $2.5 million, or $0.20 per diluted share for Q3 2019.
Revenue for the third quarter ended September 30, 2020 was $7.7 million, compared to $10.0 million for the third quarter 2019.
Net income for the third quarter 2020 was $1.1 million, or $0.09 per diluted share, compared to $2.5 million, or $0.20 per diluted share for the third quarter 2019.
Non-GAAP net income was $1.4 million for the quarter ended September 30, 2020.
Free cash flow was $1.3 million for the third quarter 2020, compared to $3.1 million for the third quarter 2019.
Revenue by Geographic Location
Forward Guidance
Due to the high degree of uncertainty created by the global impact of COVID-19, the Company withdrew its previous guidance on April 7, 2020 and is not providing any additional financial guidance at this time.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...